InMode Ltd. (NASDAQ:INMD) Shares Sold by Federated Hermes Inc.

Federated Hermes Inc. lessened its stake in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 84.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 138,227 shares of the healthcare company's stock after selling 752,741 shares during the quarter. Federated Hermes Inc. owned about 0.20% of InMode worth $2,308,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. SBI Securities Co. Ltd. purchased a new stake in InMode in the fourth quarter valued at $87,000. Farther Finance Advisors LLC lifted its holdings in shares of InMode by 26.2% in the 4th quarter. Farther Finance Advisors LLC now owns 5,555 shares of the healthcare company's stock valued at $93,000 after purchasing an additional 1,154 shares during the last quarter. Pilgrim Partners Asia Pte Ltd purchased a new stake in shares of InMode in the 4th quarter valued at about $114,000. National Bank of Canada FI boosted its position in shares of InMode by 6.2% in the 3rd quarter. National Bank of Canada FI now owns 9,985 shares of the healthcare company's stock valued at $169,000 after purchasing an additional 579 shares during the period. Finally, WINTON GROUP Ltd purchased a new position in InMode during the 4th quarter worth approximately $174,000. Institutional investors and hedge funds own 68.04% of the company's stock.

Analyst Upgrades and Downgrades

INMD has been the subject of several research analyst reports. Needham & Company LLC reissued a "hold" rating on shares of InMode in a report on Wednesday, April 9th. Jefferies Financial Group decreased their price target on shares of InMode from $16.00 to $15.00 and set a "hold" rating for the company in a research note on Monday. Finally, Barclays raised their price objective on shares of InMode from $26.00 to $29.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 5th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, InMode currently has an average rating of "Hold" and a consensus target price of $21.25.

InMode Price Performance

Shares of NASDAQ:INMD traded up $0.01 during trading on Friday, reaching $14.92. The company had a trading volume of 870,722 shares, compared to its average volume of 1,179,342. InMode Ltd. has a fifty-two week low of $13.68 and a fifty-two week high of $19.85. The stock's fifty day moving average price is $17.76 and its 200 day moving average price is $17.61. The firm has a market capitalization of $1.04 billion, a price-to-earnings ratio of 6.35 and a beta of 1.96.

InMode Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.